Dorothy LeRay is an Associate in the Firm's Litigation department. She has experience in complex commercial litigation, with a focus on innovator-side patent litigation in the pharmaceutical and healthcare industries. She has represented clients in district court, at administrative hearings, and in arbitration. From 2015 to 2016, she served as a law clerk to the Hon. Kathleen M. O'Malley of the United States Court of Appeals for the Federal Circuit. Prior to clerking, Ms. LeRay was in private practice as a litigation associate in New York, where she focused on patent and antitrust litigation.
Representing pharmaceutical company in Hatch-Waxman litigations involving first-in-class cancer drug before the District of Delaware.
Representing soda ash producer in patent litigation before the District of Delaware regarding process for manufacturing soda ash.
Represented pharmaceutical company in a patent licensing dispute regarding diagnostic products for detecting viral infections.
Represented pharmaceutical company at expert report stage in Hatch-Waxman litigation before the District of Delaware in connection with patents covering a combination therapy for HIV/AIDS.
Represented pharmaceutical company from Markman briefing through post-trial briefing in Hatch-Waxman litigation before the District of Delaware in connection with patents covering a metered dose inhaler API.
Represented university in arbitration proceeding involving inventorship of patents to groundbreaking biotechnology.
Representing pharmaceutical company in inter partes review of patents covering methods of treating cancer with therapeutic antibodies.
Represented pharmaceutical company in inter partes review of patent covering a formulation for an injectable drug.
Represented leading publishing company in antitrust litigation before the Southern District of New York in connection with allegations of price fixing in the eBook industry.
Pro Bono Litigation:
Represented former employee in contested unemployment insurance appeal proceeding.
Represented undocumented minor in Special Immigrant Juvenile Status proceeding.
- U.S. Court of Appeals, Federal Circuit
- U.S. District Court, Southern and Eastern Districts of New York
- New York
- Mandarin Chinese
- Contributor to BiologicsBlog.com
- Co-author, "Federal Circuit Strikes Down Diagnostic Patent in Latest § 101 Decision," IP Litigator, Volume 25, Number 2 (March/April 2019)
- Co-author, "Federal Circuit Affirms Dismissal of Declaratory-Judgment Action Based Under Rule Against Piecemeal Adjudication," IP Strategist, Volume 28, Number 8 (May 2018)
- Novartis AG v. Union of India: "Evergreening, " TRIPs, and "Enhanced Efficacy" Under Section 3(d), 21 J. INTELL. PROP. L. 223 (2014).
- Note, Rethinking Risks: Should Socioeconomic and Ethical Considerations Be Incorporated Into the Regulation of Genetically Modified Crops?, 26 HARV. J.L. & TECH. 375 (2012).